10X Genomics Inc (TXG)
14.95  -1.13 (-7.03%)

10X Genomics is a biotechnology company that specializes in genomic analysis, providing tools and technologies for researchers in the life sciences sector. The company develops innovative products that enable high-resolution analysis of biological systems, allowing scientists to explore complex interactions at the single-cell level. By offering advanced sequencing and gene expression solutions, 10X Genomics supports a wide range of applications in genomics, transcriptomics, and immunology, aiming to accelerate the discovery of new insights into health and disease.

SummaryNewsPress ReleasesChartHistorical
Strategic Buy Lights Up This Biotech Stock: Time to Invest?
Life sciences company Illumina Inc. (NASDAQ: ILMN) stock surged over 10% following its announcement of the acquisition of Fluent Biosciences.
Via MarketBeat · July 16, 2024
TXG Alert: Johnson Fistel Announces Investigation of 10x Genomics for Potential Securities Law Violations
Johnson Fistel, LLP is investigating 10x Genomics, Inc. (NASDAQ: TXG) (“10x Genomics” or the “Company”) for potential securities law violations. Shareholders who have incurred losses on their investment in the Company are encouraged to contact the firm to learn about potentially recovering their losses. For more details on the investigation, visit:
By Johnson Fistel, LLP · Via Business Wire · February 1, 2024
10x Genomics Inc. (NASDAQ: TXG) Sets New 52-Week High in Thursday Session
Shares of 10x Genomics, Inc. (NASDAQ: TXG) traded at a new 52-week high today and are currently trading at $59.24. So far today, approximately 246.45k shares have been exchanged, as compared to an average 30-day volume of 913.07k shares.
Via Investor Brand Network · July 20, 2023